Figure 1
Figure 1. Cumulative incidence of aGVhD II-IV (a), skin aGVhD (b), liver aGVhD (c) and GI aGVhD (d) in patients with high EMP count vs. low EMP count at engraftment.

Cumulative incidence of aGVhD II-IV (a), skin aGVhD (b), liver aGVhD (c) and GI aGVhD (d) in patients with high EMP count vs. low EMP count at engraftment.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal